Home Health Coronavirus in the world – the European Commission announces a strategy for...

Coronavirus in the world – the European Commission announces a strategy for universal vaccination

Brussels, Coronavirus, COVID, Europe, European Commission, Ukraine, University of Oxford, Vaccine, Vaccination, World, Top Stories,

European Commission proposes EU member states to adopt a common strategy prioritizing vaccination from the coronavirus of certain populations.

European Commissioner for Health Stella Kyriakides announced this in Brussels yesterday, reports DW

The EC document indicates which categories of the population should be the first to get vaccinated against coronavirus if any of the experimental vaccines are effective.

Also, the EU countries should carry out measures related to large-scale vaccination of the population, namely: purchase a sufficient number of refrigeration units and train the required number of medical personnel.

Eurocomisar focused on the safety of the vaccine – only in this case, it will be possible to use it. At the same time, she clarified that the vaccine is not a panacea for coronavirus, but it will help protect people’s lives and save the economy.

It is known that the European Commission, on behalf of all EU member states, is negotiating with companies producing vaccines against coronavirus. If current experimental vaccines prove to be suitable for use, EU member states will receive up to 1.3 billion doses of vaccines with the option to order an additional 500 million doses.

We will remind, the vaccine against coronavirus COVID-19 from the Anglo-Swedish company AstraZeneca and the University of Oxford still available before the end of 2020despite the forced pause in its testing, said the company’s chief executive.

It was also reported that as soon as there are enough materials for testing the coronavirus vaccine, they confirm their safety for research in Ukraine, then 4.2 thousand Ukrainian volunteers will be involved in the trial.

And the American biotechnology company Novavax on September 25 started the third phase coronavirus vaccine trials in the UK – human testing.

Follow us on Google News! and Flipboard!